VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: blankmind who wrote (19831)	3/18/1999 12:01:00 PM
From: VLAD	Read Replies (4) of 23519

blankmind, You're a little premature on the female product. Our focus should now be on product sales of MUSE as international markets are opened and launched. Add a domestic partner and a deal for Japan and the ball really starts to roll. Next step is the approval of Alibra as a more effective product with fewer side effects and a lower production cost which should be approved and available in early 2000. During this time period we should be hearing bits and pieces of news as to where the female SD product concept is headed. If Vivus can partner with Astra/Zeneca and then get their $ and clout behind them on a female SD product we can easily see a product on the market in 2000. And this product would be a great $ maker. Add Dr. Christ's gene therapy product concept that I think can result as a marketable product by 2001 for frosting on the cake. Vivus a $4.00/share stock??? What a joke!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next